337 related articles for article (PubMed ID: 1653518)
1. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization.
Lloyd RV; Jin L; Fields K; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518
[TBL] [Abstract][Full Text] [Related]
2. Pancreastatin secretion by pituitary adenomas and regulation of chromogranin B mRNA expression.
Jin L; Scheithauer BW; Young WF; Davis DH; Klee GG; Lloyd RV
Am J Pathol; 1996 Jun; 148(6):2057-66. PubMed ID: 8669489
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
[TBL] [Abstract][Full Text] [Related]
5. Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridization comparison with immunohistochemical and clinical data.
Schmid M; Münscher A; Saeger W; Schreiber S; Lüdecke DK
Pathol Res Pract; 2001; 197(10):663-9. PubMed ID: 11700887
[TBL] [Abstract][Full Text] [Related]
6. Distribution and regulation of proconvertases PC1 and PC2 in human pituitary adenomas.
Jin L; Kulig E; Qian X; Scheithauer BW; Young WF; Davis DH; Seidah NG; Chretien M; Lloyd RV
Pituitary; 1999 May; 1(3-4):187-95. PubMed ID: 11081197
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
9. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
[TBL] [Abstract][Full Text] [Related]
10. GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.
Münscher A; Schmid M; Saeger W; Schreiber S; Lüdecke DK
Endocr Pathol; 2001; 12(2):171-80. PubMed ID: 11579683
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chromogranin/secretogranin messenger RNAs in human pituitary adenomas.
Lloyd RV; Jin L
Diagn Mol Pathol; 1994 Mar; 3(1):38-45. PubMed ID: 8162254
[TBL] [Abstract][Full Text] [Related]
12. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
Sanno N; Teramoto A; Matsuno A; Takekoshi S; Osamura RY
J Clin Endocrinol Metab; 1995 Aug; 80(8):2518-22. PubMed ID: 7543115
[TBL] [Abstract][Full Text] [Related]
13. Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison.
Yamada S; Asa SL; Kovacs K
Virchows Arch A Pathol Anat Histopathol; 1988; 413(4):333-9. PubMed ID: 3140478
[TBL] [Abstract][Full Text] [Related]
14. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.
Zafar M; Ezzat S; Ramyar L; Pan N; Smyth HS; Asa SL
J Clin Endocrinol Metab; 1995 Dec; 80(12):3621-7. PubMed ID: 8530610
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical studies of chromogranins (A and C) in pituitary adenomas.
Oda K; Inada K; Osamura RY
Pathol Res Pract; 1991 Jun; 187(5):626-8. PubMed ID: 1717962
[TBL] [Abstract][Full Text] [Related]
17. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas.
Rosa P; Bassetti M; Weiss U; Huttner WB
J Histochem Cytochem; 1992 Apr; 40(4):523-33. PubMed ID: 1552186
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C (PKC) activity and PKC messenger RNAs in human pituitary adenomas.
Jin L; Maeda T; Chandler WF; Lloyd RV
Am J Pathol; 1993 Feb; 142(2):569-78. PubMed ID: 8434650
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analyses of oncocytic and chromophobe pituitary adenomas.
Günzl HJ; Saeger W; Diehl S; Lüdecke DK
Exp Clin Endocrinol; 1988 Sep; 92(1):51-8. PubMed ID: 2465910
[TBL] [Abstract][Full Text] [Related]
20. In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas.
Stefaneanu L; Kovacs K; Horvath E; Lloyd RV; Buchfelder M; Fahlbusch R; Smyth H
J Clin Endocrinol Metab; 1994 Jan; 78(1):83-8. PubMed ID: 8288720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
